Hypersensitivity Related to Abacavir in Two Members of a Family

Steel H Hetherington S Pearce G Syreen W Lafon S . Abacavir safety and tolerability: Experience from over 25,000 adults and children (abstract 599). Presented at the 7th European Conference on Clinical Aspects and Treatments of HIV Infection, Lisbon, Portugal, October 23–27, 1999.

Escaut L Liotier JY Albengres E Cheminot N Vittecoq D . Abacavir rechallenge has to be avoided in case of hypersensitivity reaction. AIDS 1999; 13: 1419–20.

Walensky RP Goldberg JH Daily JP . Anaphylaxis after rechallenge with abacavir. AIDS 1999; 13: 999–1000.

Naranjo CA Busto U Sellers EM Sandor P Ruiz I Roberts EA . A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–45.

Clay PG Rathbun RC Slater LN . Management protocol for abacavir-related hypersensitivity reaction. Ann Pharmacother 2000; 34: 247–9.

DeShazo RD Kemp SF . Allergic reactions to drugs and biologic agents. JAMA 1997; 278: 1895–906.

Thurmond LM Thorbon D Ravitch J Bazin C Bouvet E Hoen B . Immunohistologic characterization of skin rash observed in patients on abacavir who experience a hypersensitivity reaction. Presented at the 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Toronto, Canada, September 13–15, 2000.